title: Intravenous injection of levodopa is more effective than dantrolene as therapy for neuroleptic malignant syndrome.
authors.forename: K
authors.initials: K
authors.lastname: Nisijima
authors.forename: M
authors.initials: M
authors.lastname: Noguti
authors.forename: T
authors.initials: T
authors.lastname: Ishiguro
mesh_terms: D000328:Adult; D003620:Dantrolene / Q000008:administration & dosage / Q000627:therapeutic use*; D015259:Dopamine Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007980:Levodopa / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D009125:Muscle Relaxants, Central / Q000008:administration & dosage / Q000627:therapeutic use*; D009459:Neuroleptic Malignant Syndrome / Q000188:drug therapy*; D012559:Schizophrenia / Q000150:complications
chemical_list: D015259:Dopamine Agents; D009125:Muscle Relaxants, Central; D007980:Levodopa; D003620:Dantrolene